4.7 Article

Polypharmacy in Older Adults with Cancer

期刊

ONCOLOGIST
卷 15, 期 5, 页码 507-522

出版社

WILEY
DOI: 10.1634/theoncologist.2009-0290

关键词

Polypharmacy; Cancer; Oncology; Geriatrics; Medications; Therapy

类别

资金

  1. National Institute on Aging [T32 AG19134]
  2. Paul Beeson Career Development Award in Aging Research [1 K08 AG24842, K23 AG026749-01]

向作者/读者索取更多资源

The definition of polypharmacy ranges from the use of a large number of medications; the use of potentially inappropriate medications, which can increase the risk for adverse drug events; medication underuse despite instructions to the contrary; and medication duplication. Older adults are particularly at risk because they often present with several medical conditions requiring pharmacotherapy. Cancer-related therapy adds to this risk in older adults, but few studies have been conducted in this patient population. In this review, we outline the adverse outcomes associated with polypharmacy and present polypharmacy definitions offered by the geriatrics literature. We also examine the strengths and weaknesses of these definitions and explore the relationships among these definitions and what is known about the prevalence and impact of polypharmacy. The Oncologist 2010; 15: 507-522

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据